Chronic viral hepatitis
- PMID: 19902718
Chronic viral hepatitis
Abstract
Chronic liver disease is the tenth leading cause of death in the United States. The economic burden of liver disease is approximately 1% of the total national health care expenditure. Chronic hepatitis C is the most common cause of chronic liver disease in the United States, and chronic hepatitis B is the leading cause of liver disease worldwide. This article provides a brief overview of the evaluation and treatment of chronic hepatitis B and C infection.
Similar articles
-
[A report from the Chinese National Fourteenth Symposium on Viral Hepatitis and Liver Diseases].Zhonghua Gan Zang Bing Za Zhi. 2009 Aug;17(8):636-7. Zhonghua Gan Zang Bing Za Zhi. 2009. PMID: 19719931 Chinese. No abstract available.
-
Economics of chronic hepatitis B and hepatitis C.J Hepatol. 2007 Oct;47(4):608-17. doi: 10.1016/j.jhep.2007.07.016. Epub 2007 Jul 30. J Hepatol. 2007. PMID: 17697724 Review.
-
[Therapy of viral hepatitis].Z Gastroenterol. 2002 Dec;40 Suppl 2:31-2. doi: 10.1055/s-2002-35902. Z Gastroenterol. 2002. PMID: 12467003 German. No abstract available.
-
Diagnosis and management of chronic viral hepatitis: antigens, antibodies and viral genomes.Best Pract Res Clin Gastroenterol. 2008;22(6):1031-48. doi: 10.1016/j.bpg.2008.11.004. Best Pract Res Clin Gastroenterol. 2008. PMID: 19187865 Review.
-
[Chronic hepatitis C and B. What can be accomplished with antiviral therapy].MMW Fortschr Med. 2007 Feb 15;149(7):14. MMW Fortschr Med. 2007. PMID: 17615650 German. No abstract available.
Cited by
-
Health-Related Quality of Life in Patients with Chronic Hepatitis B: A Meta-Analysis of Observational Studies.Iran J Public Health. 2023 Mar;52(3):453-462. doi: 10.18502/ijph.v52i3.12129. Iran J Public Health. 2023. PMID: 37124905 Free PMC article. Review.